Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-19-006122
Filing Date
2019-02-11
Accepted
2019-02-11 13:00:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv512934_sc13g.htm SC 13G 35718
  Complete submission text file 0001144204-19-006122.txt   37338
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Subject) CIK: 0000887151 (see all company filings)

EIN.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42745 | Film No.: 19583996
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3300 SOUTH DIXIE HIGHWAY, SUITE 1-365 WEST PALM BEACH FL 33405
Business Address 3300 SOUTH DIXIE HIGHWAY, SUITE 1-365 WEST PALM BEACH FL 33405 (858) 829-6713
Alimco Financial Corp (Filed by) CIK: 0001763340 (see all company filings)

EIN.: 770057842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G